ES2175181T3 - Analogos hexaciclicos de camptotecina y su procedimiento de preparacion. - Google Patents

Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.

Info

Publication number
ES2175181T3
ES2175181T3 ES96944606T ES96944606T ES2175181T3 ES 2175181 T3 ES2175181 T3 ES 2175181T3 ES 96944606 T ES96944606 T ES 96944606T ES 96944606 T ES96944606 T ES 96944606T ES 2175181 T3 ES2175181 T3 ES 2175181T3
Authority
ES
Spain
Prior art keywords
hexaciclic
analogs
camptotecine
preparation procedure
camptotechine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96944606T
Other languages
English (en)
Inventor
Angelo Bedeschi
Ilaria Candiani
Franco Zarini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2175181T3 publication Critical patent/ES2175181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS ANALOGOS DE CAMPTOTECINA HEXACICLICA QUE POSEEN UN AZA MIEMBROS UNIDO AL ANILLO (A) DE LA CAMPTOTECINA EN LAS POSICIONES 9 Y 10. DICHOS COMPUESTOS POSEEN UNA IMPORTANTE ACTIVIDAD ANTITUMORAL MEDIANTE LA INHIBICION DE LA TOPOISOMERASA (I).
ES96944606T 1996-01-10 1996-12-17 Analogos hexaciclicos de camptotecina y su procedimiento de preparacion. Expired - Lifetime ES2175181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600438.7A GB9600438D0 (en) 1996-01-10 1996-01-10 Hexacyclic camptothecin analogues, and process for preparing them

Publications (1)

Publication Number Publication Date
ES2175181T3 true ES2175181T3 (es) 2002-11-16

Family

ID=10786827

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96944606T Expired - Lifetime ES2175181T3 (es) 1996-01-10 1996-12-17 Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.

Country Status (7)

Country Link
US (1) US5990120A (es)
EP (1) EP0813535B1 (es)
JP (1) JPH11502871A (es)
DE (1) DE69620593T2 (es)
ES (1) ES2175181T3 (es)
GB (1) GB9600438D0 (es)
WO (1) WO1997025332A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702807D0 (en) 1997-02-12 1997-04-02 Pharmacia & Upjohn Spa Alkynyl-substituted camptothecins and process for their preparation
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US20070207149A1 (en) 2004-04-27 2007-09-06 Wellstat Biologics Corporation Cancer treatment using viruses and camptothecins
CN1300147C (zh) * 2004-10-18 2007-02-14 中国药科大学 喜树碱衍生物的制备方法
EP1907015B1 (en) 2005-07-14 2012-01-11 Wellstat Biologics Corporation Cancer treatment using viruses, fluoropyrimidines and camptothecins
CN100586952C (zh) * 2006-11-10 2010-02-03 中国药科大学 噁唑骈喜树碱酯衍生物及其制备方法和用途
CN102659800B (zh) * 2012-05-11 2014-09-03 中国药科大学 一类低氧激活抗肿瘤化合物及其用途
WO2017053920A1 (en) 2015-09-25 2017-03-30 Zy Therapeutics Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
CN108017656B (zh) * 2016-11-03 2020-01-07 深圳瀜新生物科技有限公司 喜树碱衍生物及其在制备抗肿瘤药物中的应用
CN109467563B (zh) * 2018-06-08 2021-08-03 浙江大学 一种喜树碱衍生物及其在制备抗炎症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
GB9319944D0 (en) * 1993-09-28 1993-11-17 Erba Carlo Spa Process for the preparation of 9-amino camptothecin
DE69417526T2 (de) * 1993-12-01 1999-09-09 Ichikawa Gosei Chemical Co. Ltd. Verfahren zur Herstellung von cis-1-Aminoindan-2-ol
US5670500A (en) * 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs

Also Published As

Publication number Publication date
DE69620593D1 (de) 2002-05-16
WO1997025332A1 (en) 1997-07-17
JPH11502871A (ja) 1999-03-09
EP0813535A1 (en) 1997-12-29
DE69620593T2 (de) 2002-11-28
EP0813535B1 (en) 2002-04-10
GB9600438D0 (en) 1996-03-13
US5990120A (en) 1999-11-23

Similar Documents

Publication Publication Date Title
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
PT758248E (pt) Formulacoes para o factor ix
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
FI945363A (fi) Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä
HUP0100065A2 (hu) Savérzékeny vegyületet tartalmazó új kúp gyógyszerforma
TR200001603T2 (tr) Yeni bileşikler
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ES2173858T3 (es) Analogos de huperzina a.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
ES2175181T3 (es) Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.
GB2380939B (en) Treatment or prevention of auto-immune diseases
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
FR2607004B1 (fr) Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
DE69828043D1 (de) Fluoridfreie zahnremineralisierung
MX9805506A (es) Uso medico novedoso de un inhibidor de la dispepsia relacionada con acido para el tratamiento de sintomas dispepticos.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
NO980296L (no) Forbedrede terapeutiske midler
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EA200000112A1 (ru) Новая композиция
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 813535

Country of ref document: ES